Portfolio

LUMO Fund II

×

Aiosyn’s AI solutions empower pathologists to make their work more accurate, efficient and effective, for the benefit of patients and society.


Aiosyn combines science and engineering to transform top-tier research into leading AI-powered medical products from the heart of Europe. 

It offers a flexible and interoperable AI platform to create biomarker solutions, ready to accommodate any size of workload at global scale, and supports CROs and biopharma with AI-powered solutions to identify novel pathology-based biomarkers that can accelerate drug development.